EQUITY RESEARCH MEMO

Alira Health

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)65/100

Alira Health is a global healthcare consultancy and contract research organization (CRO) headquartered in Boston, USA. Founded in 2015, the company integrates consulting, CRO services, patient engagement training, and proprietary technology to optimize clinical development and commercialization for life sciences companies. Its core mission is to humanize healthcare by centering the patient voice throughout the product lifecycle. By combining evidence generation and application, Alira helps clients navigate complex regulatory and market landscapes. The company operates at the intersection of digital health and clinical research, leveraging technology to enhance patient-centricity and operational efficiency. While privately held and not publicly traded, Alira Health has carved a niche in the competitive CRO market by emphasizing patient engagement and real-world evidence. Its growth prospects are tied to the increasing demand for decentralized clinical trials and personalized medicine solutions.

Upcoming Catalysts (preview)

  • Q3 2026Launch of new proprietary patient engagement platform70% success
  • TBDMajor pharma partnership for decentralized trial solutions60% success
  • H2 2026Expansion into European market with new office or acquisition50% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)